Clinical Trial Update: Pyrosequencing of the BRAFV600E Mutation

View source ↗

Summary

A completed clinical trial evaluating pyrosequencing to detect the BRAFV600E mutation in thyroid neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Neoplasms

Snippet

Sponsor: Chungnam National University | Conditions: Thyroid Neoplasms | Status: COMPLETED